Published November 20, 2025 | Version v2
Working paper Open

Understanding Glycation: Membrane Integrity, Metabolism, and the Role of Ketosis

Authors/Creators

  • 1. Ideal Protein Company Inc.

Description

Glycation is a fundamental biochemical process arising from the interaction between excess glucose and cellular macromolecules. Although long recognized as a hallmark of diabetes and aging, its systemic consequences extend far beyond hemoglobin modification. This white paper examines glycation as a pervasive mechanism of cellular dysfunction, with emphasis on its effects on membrane proteins, lipids, and organelles. By exploring these less-studied dimensions, it provides a unifying framework connecting hyperglycemia, membrane rigidity, oxidative stress, and impaired signaling - core features of metabolic syndrome and insulin resistance.

Cell membranes are dynamic structures that regulate transport, communication, and metabolism. Their components - proteins and lipids, are susceptible to glycation, which compromises both flexibility and function. The formation of advanced glycation end-products (AGEs) leads to oxidative stress, inflammatory signaling, and cumulative molecular damage. Understanding how glycation affects membranes at multiple levels, including the cell surface, nucleus, and mitochondria, offers new insight into metabolic dysfunction and potential therapeutic strategies, focusing on ketosis as a viable approach to address this problem.

Files

Understanding_Glycation_Membrane_Integrity_Ketosis_Tran_Tien_Chanh_V2_2025.pdf

Additional details

Dates

Created
2025-11-20

References

  • Ahmed N. Advanced glycation end products—role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67(1):3-21. doi:10.1016/j.diabres.2004.09.003. Annibal A, Riemer T, Jovanovic O, et al. Structural, biological and biophysical properties of glycated and glycoxidized phosphatidylethanolamines. Free Radic Biol Med. 2016;95:293-307. doi:10.1016/j.freeradbiomed.2016.03.011 Bansal S, Burman A, Tripathi AK. Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes. World J Diabetes. 2023;14(8):1146-1162. doi:10.4239/wjd.v14.i8.1146 Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820. Ghosh AR, Bhattacharya R, Bhattacharya S, et al. Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation. Diabetes. 2016;65(11):3440-3452. doi:10.2337/db16-0331Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597-605. doi:10.1161/CIRCULATIONAHA.106.621854. Huang J, Yancey PG, Tao H, et al. Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity. Nutrients. 2020;12(7):1937. Published 2020 Jun 30. doi:10.3390/nu12071937 Levi V, Villamil Giraldo AM, Castello PR, Rossi JP, González Flecha FL. Effects of phosphatidylethanolamine glycation on lipid-protein interactions and membrane protein thermal stability. Biochem J. 2008;416(1):145-152. doi:10.1042/BJ20080618 Lyons TJ, Jenkins AJ. Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Rev (Alex). 1997;5(4):365-391. Manno S, Mohandas N, Takakuwa Y. ATP-dependent mechanism protects spectrin against glycation in human erythrocytes. J Biol Chem. 2010;285(44):33923-33929. doi:10.1074/jbc.M110.126896 Miyazawa T, Ibusuki D, Yamashita S, Nakagawa K. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry. Ann N Y Acad Sci. 2008;1126:291-294. doi:10.1196/annals.1433.033 Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014;25(1):42-52. doi:10.1016/j.tem.2013.09.002. Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789-796. doi:10.1038/ejcn.2013.116. Pitocco D, Hatem D, Riente A, et al. Evaluating Red Blood Cells' Membrane Fluidity in Diabetes: Insights, Mechanisms, and Future Aspects. Diabetes Metab Res Rev. 2025;41(1):e70011. doi:10.1002/dmrr.70011 Pun PB, Logan A, Darley-Usmar V, et al. Mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetes. Free Radic Biol Med. 2014;67:437-450. doi:10.1016/j.freeradbiomed.2013.11.025. Rosca MG, Mustata TG, Kinter MT, et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol. 2005;289(2):F420-F430. doi:10.1152/ajprenal.00415.2004 Schilling J, Brix K. Turnover of membrane proteins and its regulation in mammalian cells. Biochim Biophys Acta. 2013;1828(6):1524-1533. doi:10.1016/j.bbamem.2013.02.004. Shaklai N, Garlick RL, Bunn HF. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984;259(6):3812-3817. Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211-214. doi:10.1126/science.1227166 Thornalley PJ. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J. 1990;269(1):1-11. doi:10.1042/bj2690001 Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001;56:1-21. doi:10.1210/rp.56.1.1 Verdin E, Ott M. 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol. 2015;16(4):258-264. doi:10.1038/nrm3931 Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004;70(3):309-319. doi:10.1016/j.plefa.2003.09.007 Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both?. Curr Diab Rep. 2014;14(1):453. doi:10.1007/s11892-013-0453-1 Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008;5:36. Published 2008 Dec 19. doi:10.1186/1743-7075-5-36 Winocour PD, Watala C, Kinglough-Rathbone RL. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects. Thromb Haemost. 1992;67(5):567-571. Yokota M, Masaki H, Okano Y, Tokudome Y. Effect of glycation focusing on the process of epidermal lipid synthesis in a reconstructed skin model and membrane fluidity of stratum corneum lipids. Dermatoendocrinol. 2017;9(1):e1338992. Published 2017 Oct 4. doi:10.1080/19381980.2017.1338992